153 related articles for article (PubMed ID: 35417006)
1. COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Cortellini A; Gennari A; Pommeret F; Patel G; Newsom-Davis T; Bertuzzi A; Viladot M; Aguilar-Company J; Mirallas O; Felip E; Lee AJX; Dalla Pria A; Sharkey R; Brunet J; Carmona-García M; Chester J; Mukherjee U; Scotti L; Dolly S; Sita-Lumsden A; Ferrante D; Van Hemelrijck M; Moss C; Russell B; Seguí E; Biello F; Krengli M; Marco-Hernández J; Gaidano G; Patriarca A; Bruna R; Roldán E; Fox L; Pous A; Griscelli F; Salazar R; Martinez-Vila C; Sureda A; Loizidou A; Maluquer C; Stoclin A; Iglesias M; Pedrazzoli P; Rizzo G; Santoro A; Rimassa L; Rossi S; Harbeck N; Sanchez de Torre A; Vincenzi B; Libertini M; Provenzano S; Generali D; Grisanti S; Berardi R; Tucci M; Mazzoni F; Lambertini M; Tagliamento M; Parisi A; Zoratto F; Queirolo P; Giusti R; Guida A; Zambelli A; Tondini C; Maconi A; Betti M; Colomba E; Diamantis N; Sinclair A; Bower M; Ruiz-Camps I; Pinato DJ;
J Natl Cancer Inst; 2022 Jul; 114(7):979-987. PubMed ID: 35417006
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
[TBL] [Abstract][Full Text] [Related]
3. Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry.
Cortellini A; Salazar R; Gennari A; Aguilar-Company J; Bower M; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Lee AJ; Carmona-García M; Newsom-Davis T; Van Hemelrijck M; Plaja A; Zambelli A; Tondini C; Generali D; Bertulli R; Diamantis N; Mukherjee U; Rizzo G; Yu T; Zoratto F; Bruna R; Sureda A; Martinez-Vila C; Cantini L; Mazzoni F; Grosso F; Parisi A; Saponara M; Prat A; Pinato DJ;
Eur J Cancer; 2022 Jul; 170():10-16. PubMed ID: 35576848
[TBL] [Abstract][Full Text] [Related]
4. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
Fei M; Tong F; Tao X; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
[TBL] [Abstract][Full Text] [Related]
5. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
6. Prognostic accuracy of inflammatory markers in predicting risk of ICU admission for COVID-19: application of time-dependent receiver operating characteristic curves.
Geraili Z; Hajian-Tilaki K; Bayani M; Hosseini SR; Khafri S; Ebrahimpour S; Javanian M; Babazadeh A; Shokri M
J Int Med Res; 2022 Jun; 50(6):3000605221102217. PubMed ID: 35701893
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
Cortellini A; Dettorre GM; Dafni U; Aguilar-Company J; Castelo-Branco L; Lambertini M; Gennatas S; Angelis V; Sita-Lumsden A; Rogado J; Pedrazzoli P; Viñal D; Prat A; Rossi M; Berardi R; Alonso-Gordoa T; Grisanti S; Dimopoulou G; Queirolo P; Pradervand S; Bertuzzi A; Bower M; Arnold D; Salazar R; Tucci M; Harrington KJ; Mazzoni F; Mukherjee U; Tsourti Z; Michielin O; Pommeret F; Brunet J; Vincenzi B; Tonini G; Patriarca A; Biello F; Krengli M; Tabernero J; Pentheroudakis G; Gennari A; Peters S; Romano E; Pinato DJ
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450384
[TBL] [Abstract][Full Text] [Related]
8. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.
Torun A; Çakırca TD; Çakırca G; Portakal RD
Rev Assoc Med Bras (1992); 2021 Mar; 67(3):431-436. PubMed ID: 34468610
[TBL] [Abstract][Full Text] [Related]
9. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
11. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
[TBL] [Abstract][Full Text] [Related]
12. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
[TBL] [Abstract][Full Text] [Related]
13. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
Dettorre GM; Dolly S; Loizidou A; Chester J; Jackson A; Mukherjee U; Zambelli A; Aguilar-Company J; Bower M; Sng CCT; Salazar R; Bertuzzi A; Brunet J; Mesia R; Sita-Lumsden A; Seguí E; Biello F; Generali D; Grisanti S; Seeva P; Rizzo G; Libertini M; Maconi A; Moss C; Russell B; Harbeck N; Vincenzi B; Bertulli R; Ottaviani D; Liñan R; Marrari A; Carmona-García MC; Chopra N; Tondini CA; Mirallas O; Tovazzi V; Fotia V; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué A; Lee AJX; Newsom-Davis T; García-Illescas D; Reyes R; Wong YNS; Ferrante D; Scotti L; Marco-Hernández J; Ruiz-Camps I; Patriarca A; Rimassa L; Chiudinelli L; Franchi M; Santoro A; Prat A; Gennari A; Van Hemelrijck M; Tabernero J; Diamantis N; Pinato DJ;
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753569
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
15. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
18. Are the C-reactive protein/albumin ratio (CAR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (NLR) novel inflammatory biomarkers in the early diagnosis of postoperative complications after laparoscopic sleeve gastrectomy?
Bora Makal G; Yıldırım O
Obes Res Clin Pract; 2020; 14(5):467-472. PubMed ID: 32807712
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil and Platelet to Lymphocyte Ratios in Associating with Blood Glucose Admission Predict the Functional Outcomes of Patients with Primary Brainstem Hemorrhage.
Fan Z; Hao L; Chuanyuan T; Jun Z; Xin H; Sen L; Juan Q; Cao Y; Mu Y
World Neurosurg; 2018 Aug; 116():e100-e107. PubMed ID: 29689388
[TBL] [Abstract][Full Text] [Related]
20. Could Some Laboratory Parameters Predict Mortality in COVID-19?
Nurlu N; Ozturk OO; Cat A; Altunok ES; Gumus A
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
